Clinical trial for Chronic Fatigue Syndrome
Official title Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS
ClinicalTrials.gov ID: NCT07009691
What this study is testing
- What it's testing
- This study is testing whether hydrogen water can reduce fatigue and improve daily functioning in people with ME/CFS. It also looks at whether heart rate variability can predict who benefits.
- Who it's for
- You may be able to join if you are an adult with chronic fatigue syndrome and can drink water.
- What's involved
- You will drink hydrogen water at home and keep a diary of your symptoms. The study will also measure your heart rate variability to see if it helps predict results.
- Time commitment
- The study lasts several weeks and requires you to drink the water daily and attend a few check‑in visits.
- Time commitment: about 16 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Meets Institute of Medicine criteria for myalgic encephalomyelitis/chronic fatigue syndrome -
You likely can't join if
- Medical illness that explains presenting fatigue; Any psychosis.
The study team makes the final eligibility decision.
Where it is enrolling
- Stony Brook, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 16 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Stony Brook, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.